BioVersys AGFRA:W33 -0.71%7 OCF Yield % is -13.90 as of Jul. 06, 2026. GuruFocus rates FRA:W33 with a GF Score™ of 7/100. Among 1,410 Biotechnology companies, BioVersys AG ranks worse than 61.77% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
BioVersys AG OCF Yield % Related Terms
BioVersys AG OCF Yield % Historical Data
* Premium members only.
The historical data trend for BioVersys AG's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioVersys AG OCF Yield % Chart
BioVersys AG Annual Data
Trend
Dec24
Dec25
OCF Yield %
0.00
-16.35
BioVersys AG Semi-Annual Data
Jun24
Dec24
Jun25
Dec25
OCF Yield %
0.00
0.00
-9.66
-18.35
FRA:W33 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, BioVersys AG's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioVersys AG OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BioVersys AG's OCF Yield % distribution charts can be found below:
* The bar in red indicates where BioVersys AG's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioVersys AG (FRA:W33) has a OCF Yield % of -13.90 as of Jul. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on BioVersys AG and its competitors. According to the industry distribution chart, BioVersys AG ranks #871 out of 1410 companies in the Biotechnology industry, placing it in the top 61.8%.
Is BioVersys AG's OCF Yield % too high?
BioVersys AG's current OCF Yield % is -13.90. Based on the distribution chart, BioVersys AG ranks #871 out of 1410 companies in the Biotechnology industry, which is below the industry midpoint. Overall, BioVersys AG has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does BioVersys AG's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BioVersys AG ranks #871 out of 1410 companies for OCF Yield %. This places BioVersys AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on BioVersys AG and its competitors. BioVersys AG's current OCF Yield % is -13.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioVersys AG stock overvalued right now?
BioVersys AG (FRA:W33) has a current OCF Yield % of -13.90. The current OCF Yield % is -13.90. BioVersys AG's overall GF Score™ is 7/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For BioVersys AG (FRA:W33), the current OCF Yield % is -13.90 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BioVersys AG is a multi-asset, clinical-stage biopharmaceutical company. The Group focuses on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant (MDR) bacteria. The pipeline products of the company include BV100 - novel MoA, Alpibectir - novel potentiator MoA, BV200 - novel anti-virulence MoA, BV500 - novel series, and others. It has one operating segment focusing on the research and development and prospective commercialization of antibiotics. Geographically, the company operates in Switzerland and France.
7GF Score
Get the complete analysis for FRA:W33
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:W33 has been successfully added to your 